Skip to main content
KLRA logo
KLRA
(NASDAQ)
Kailera Therapeutics, Inc.
$16.43-- (--)
Loading... - Market loading

Kailera Therapeutics (KLRA) Stock Price & Financial Analysis

Kailera Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.57 - $16.44
52-Week High$28.23
52-Week Low$15.15
Open$15.60
Volume523.30K
Average Volume (3M)633.10K
Market Cap350.68K
Shares Outstanding21.61K
Price to Book (P/B)0.00
EV/EBITDA0.65
50-Day MA$18.42
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Kailera Therapeutics

What is the current stock price for KLRA?

As of the latest trading session, KLRA stock trades at $16.23. The 52-week range is $15.15–$28.23, with a day range of $15.57–$16.44.

What is the P/E ratio for KLRA?

The P/E ratio (Price-to-Earnings) for KLRA is shown in the Key Statistics section. This valuation metric helps compare Kailera Therapeutics, Inc. to industry peers.

Does KLRA pay dividends?

Kailera Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KLRA?

Based on 4 analysts, the consensus for KLRA is Buy.

What is the market cap of KLRA?

Kailera Therapeutics's market capitalization is $350,681.61, classifying it as a micro-cap company. Kailera Therapeutics operates in the Healthcare sector within the Biotechnology industry.